ABG 30

Pill imprint ABG 30 has been identified as Morphine sulphate extended-release 30 mg.

Morphine is used in the treatment of pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy.

Morphine 30 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
See also related documents.

Morphine sulphate extended-release Images

Imprint:
ABG
30
Strength:
30 mg
Color:
Purple
Shape:
Round
Availability:
Prescription only
Drug Class:
Narcotic analgesics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-3512
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
42858-0802 Rhodes Pharmaceuticals
00591-3741 Watson Pharmaceuticals, Inc.
66336-0173 Dispensing Solutions Inc. (repackager)
49999-0846 Lake Erie Medical and Surgical Supply (repackager)
55887-0092 Diversified Healthcare Services Inc (repackager)
10544-0379 Blenheim Pharmacal Inc (repackager)
16590-0607 Stat RX USA LLC (repackager)
54868-4033 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Drug DetailsPrint Page

Morphine sulphate extended-release 30 mg ABG 30
Morphine sulphate extended-release 30 mg ABG 30
Advertisement

Morphine Sulphate Extended-Release is associated with the treatment of:

Search Again

Search by Imprint, Shape or Color

Note: All fields optional. Use the pill finder to identify medications by visual appearance or name.

Imprint:
Color:
Shape:

Search by Drug Name

Drug Name:

Search by National Drug Codes (NDC)

Did you find this page helpful? Yes No

(web4)